An unusual cause of hypertension and renal failure: A case series of a family with Alagille syndrome

Nephrology Dialysis Transplantation

Volumn 25, Issue 5, 2010, Pages 1501-1506

  Shrivastava, Rajesh ^a   Williams, Andrew ^a   Mikhail, Ashraf ^a   Roberts, David ^a   Richards, Martyn ^a   Aithal, Vandse ^a  

^a MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Alagille syndrome; Haemodialysis; Hypertension; Renal failure; Renal transplant

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; JAGGED1; UREA; VISUAL PIGMENT;

ADULT; ALAGILLE SYNDROME; ARTERY OCCLUSION; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BREAST CARCINOMA; CANCER MORTALITY; CATARACT; CELIAC ARTERY; CLINICAL ARTICLE; DISEASE SEVERITY; DYSPNEA; FACE DYSMORPHIA; FAMILY; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION; GENETIC ANALYSIS; GYNECOLOGIC CANCER; HEART LEFT VENTRICLE HYPERTROPHY; HEART MURMUR; HEART VALVE STENOSIS; HEMODIALYSIS; HETEROZYGOSITY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; KIDNEY ASYMMETRY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LIVER HEMANGIOMA; MALE; METASTASIS; MITRAL VALVE REGURGITATION; OBSTRUCTIVE JAUNDICE; PHENOTYPE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RENAL ARTERY; SINUS BRADYCARDIA; SUBCLAVIAN ARTERY; SYSTOLIC HEART MURMUR; SYSTOLIC HYPERTENSION; URINARY TRACT INFECTION;

ADULT; AGED; ALAGILLE SYNDROME; CALCIUM-BINDING PROTEINS; CHILD; FEMALE; HUMANS; HYPERTENSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED;

EID: 77951676607     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp692     Document Type: Article

References (35)

1. Alagille D, Estrada A, Hadchouel M, et al. Syndromic paucity of in-terlobular bile ducts (Alagille syndrome or arteriohepaticdysplasia): review of 80 cases. J Pediatr 1987; 110: 195-200 (Pubitemid 17016845)
2. Spinner NB, Colliton RP, Crosnier C, et al. Jagged1 mutations in Ala-gille syndrome. Hum Mutat 2001; 17: 18-33
3. Oda T, Elkahloun AG, Pike BL, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997; 16: 235-242 (Pubitemid 27280205)
4. Li L, Krantz ID, Deng Y, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997; 16: 243-251 (Pubitemid 27280206)
5. Warthen DM, Moore EC, Kamath BM, et al. Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Hum Mutat 2006; 27: 436-443
6. Fischer A, Klamt B, Schumacher N, et al. Phenotypic variability in Hey2-/-mice and absence of HEY2 mutations in patients with congenital heart defects or Alagille syndrome. Mamm Genome 2004; 15: 711-716 (Pubitemid 39159196)
7. McDaniell R, Warthen DM, Sanchez-Lara PA, et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006; 79: 169-173 (Pubitemid 43927389)
8. Kamath BM, Krantz ID, Spinner NB, et al. Piccoli Monozygotic twins with a severe form of Alagille syndrome and phenotypic discordance. Am J Med Genet 2002; 112: 194-197
9. Kamath BM, Bason L, Piccoli DA, et al. Consequences of JAG1 mutations. J Med Genet 2003; 40: 891-895 (Pubitemid 38117538)
10. Crosnier C, Attié-Bitach T, Encha-Razavi F, et al. JAGGED1 gene expression during human embryogenesis elucidates the wide phe-notypic spectrum of Alagille syndrome. Hepatology 2000; 32: 574-581
11. Piccoli DA, Spinner NB. Alagille syndrome and the Jagged1 gene. Semin Liver Dis 2001; 21: 525-534
12. Xue Y, Gao X, Lindsell CE, et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 1999; 8: 723-730 (Pubitemid 29189039)
13. Gale NW, Dominguez MG, Noguera I, et al. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA 2004; 101: 15949-15954 (Pubitemid 39507907)
14. Duarte A, Hirashima M, Benedito R, et al. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev 2004; 18: 2474-2478 (Pubitemid 39362889)
15. Krebs LT, Shutter JR, Tanigaki K, et al. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev 2004; 18: 2469-2473 (Pubitemid 39362888)
16. High FA, Lu MM, Pear WS, et al. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc Natl Acad Sci USA 2008; 105: 1955-1959
17. High FA, Zhang M, Proweller A, et al. An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J Clin Invest 2007; 117: 353-363 (Pubitemid 46203964)
18. McElhinney DB, Krantz ID, Bason L, et al. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 2002; 106: 2567-2574 (Pubitemid 35340693)
19. Danks DM, Campbell PE, Jack I, et al. Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child 1977; 52: 360-367 (Pubitemid 8101379)
20. Krantz ID, Piccoli DA, Spinner NB. Alagille syndrome. J Med Genet 1997; 34: 152-157
21. Tzakis AG, Reyes J, Tepetes K, et al. Liver transplantation for Alagille's syndrome. Arch Surg 1993; 128: 337-339 (Pubitemid 23077519)
22. Deprettere A, Portmann B, Mowat AP. Syndromic paucity of the intrahepatic bile ducts: diagnostic difficulty; severe morbidity throughout early childhood. J Pediatr Gastroenterol Nutr 1987; 6: 865-871 (Pubitemid 18046914)
23. Silberbach M, Lashley D, Reller MD, et al. Arteriohepatic dyspla-sia and cardiovascular malformations. Am Heart J 1994; 127: 695-699
24. Puklin JE, Riely CA, Simon RM, et al. Anterior segment and retinal pigmentary abnormalities in arteriohepatic dysplasia. Ophthalmology 1981; 88: 337-347
25. Hoffenberg EJ, Narkewicz MR, Sondheimer JM, et al. Outcome of syn-dromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy. J Pediatr 1995; 127: 220-224
26. Kamath BM, Spinner NB, Emerick KM, et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 2004; 109: 1354-1358
27. Emerick KM, Rand EB, Goldmuntz E, et al. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology 1999; 29: 822-829 (Pubitemid 29109597)
28. Riely CA, Cotlier E, Jensen PS, et al. Arteriohepatic dysplasia: a benign syndrome of intrahepatic cholestasis with multiple organ involvement. Ann Intern Med 1979; 91: 520-527 (Pubitemid 10188846)
29. Dommergues JP, Gubler MC, Habib R, et al. Renal involvement in the Alagille syndrome. Arch Pediatr 1994; 1: 411-413
30. Bérard E, Sarles J, Triolo V, et al. Renovascular hypertension and vascular anomalies in Alagille syndrome. Pediatr Nephrol 1998; 12: 121-124 (Pubitemid 28165800)
31. Martin SR, Garel L, Alvarez F. Alagille's syndrome associated with cystic renal disease. Arch Dis Child 1996; 74: 232-235 (Pubitemid 26093819)
32. Hyams JS, Berman MM, Davis BH. Tubulointerstitial nephropathy associated with arteriohepatic dysplasia. Gastroenterology 1983; 85: 430-434
33. Habib R, Dommergues JP, Gubler MC, et al. Glomerular mesangio-lipidosis in Alagille syndrome (arteriohepatic dysplasia). Pediatr Nephrol 1987; 1: 455-464 (Pubitemid 18016646)
34. Schonck M, Hoorntje S, van Hooff J. Renal transplantation in Alagille syndrome. Nephrol Dial Transplant 1998; 13: 197-199 (Pubitemid 28033605)
35. Harendza S, Hübner CA, Gläser C, et al. Renal failure and hypertension in Alagille syndrome with a novel JAG1 mutation. J Nephrol 2005; 18: 312-317 (Pubitemid 41078952)